Programme - 24th Biennial International Congress on
Transkript
Programme - 24th Biennial International Congress on
European and Mediterranean League against Thrombotic Diseases EMLTD 24 th Biennial International Congress on Thrombosis T L M Istanbul, Turkey - May 4-7, 2016 HALIÇ CONGRESS CENTER E www.thrombosis2016.org 1 WELCOME Dear Colleagues, On behalf of the Congress Executive Board, the local Organizing Committee and the Council of the European and Mediterranean League against Thrombotic Diseases, it is with great pleasure and privilege to invite you to the 24th International Congress on Thrombosis to be held in Istanbul, Turkey on May 4-7, 2016. This will be the third ICT Congress held in Turkey. The first two were held in 1974 and 2008 by Prof. Dr. Orhan N. Ulutin who was a founding member of many international organizations, including EMLTD and the Hemostasis and Thrombosis Congresses in Turkey. The Scientific Programme of the upcoming Congress will cover topics ranging from various fields of clinical and laboratory issues on thrombosis and related scientific issues. The Congress will feature contemporary lecture topics, evidence-based hematology sessions, and satellite symposia covering the latest developments on thrombotic diseases. The education program of the Congress will strike a balance between the needs of both basic and clinical issues. We took great care in designing a program that caters to the needs of younger attendees through discussions that foster scientific exchange, presentations, awards and special social functions. The cultural program also promises to be appealing, and will highlight Istanbul’s proud culture and national heritage. Istanbul’s history dates back to the end of the 4th century B.C., and relics from the Hellenic, Roman, Byzantine and Ottoman periods are scattered throughout the city. The Hagia Sophia, Basilica Cistern, Blue Mosque, Grand Bazaar, Topkapı Palace and Turkish Baths, all contribute to Istanbul’s unique experience as an open-air museum. You will have the opportunity to discover Turkish music, art and architecture, enjoy delicious Turkish and Ottoman cuisines, and experience worldrenowned Turkish hospitality. Istanbul’s unique geography at the crossroads of Europe and Asia, allows the world “to meet where the continents meet”. The Haliç Congress Center will be the venue for the Congress. The Haliç Congress Center is ideally situated along the shores of the Golden Horn. The Center is easily accessible from hotels and via public transportation to and from the entire city. D T L Once again, on behalf of the Executive Board of EMLTD and of the Organizing Committee, I would like to invite you to the 24th International Congress on Thrombosis. I sincerely believe that you will enjoy both the scientific and cultural aspects of the programme, and the pleasure of spring time in Istanbul. M E I look forward to personally welcoming you to Istanbul in May, 2016! Ahmet Muzaffer Demir, M.D. President of 24th International Congress on Thrombosis 2 GENERAL INFORMATION VENUE Haliç Congress Center Istambul Sutluce Mah. Karaagac Cad. No.19 34445 Beyoglu Istanbul, Turkey BADGE Each participant will receive a name badge upon check-in at the Registration Desk. The badge will be considered as an official meeting document and should be carried all the time in order to get granted access to the meeting rooms. REGISTRATION DESK The registration desk is located in the Main Hall, next to the entrance and it will be open on: Wednesday Thursday Friday Saturday May 4th May 5th May 6th May 7th 12:00 - 18:00 08:15 - 19:00 08:15 - 19:00 08:15 - 14:00 ELECTRONIC DEVICES As a courtesy to your colleagues, we invite you to turn off or silence all electronic devices during the educational, plenary sessions and symposiums. T L M WI-FI Internet access is available through WIFI connection. CATERING FACILITIES Lunch boxes will be served in the exhibitor area, at the time specified in the programme. Coffee breaks will be also provided during the Congress. E EMLTD European and Mediterranean League against Thrombotic Diseases 3 Committee CONGRESS EXECUTIVE COMMITTEE Ali Taher (Lebanon) Ayşegül Ünüvar (Istanbul, Turkey) President Z. Tazi (Morocco) Fikriye Uras (Istanbul, Turkey) Ahmet Muzaffer Demir (Edirne, Turkey) Iovtchо Boyanov Topalov (Bulgaria) Ayşen Yarat (Istanbul, Turkey) Vice-President Anthi Travlou (Greece) Bülent Zülfikar (Istanbul, Turkey) Turgut Ulutin (Istanbul, Turkey) Maria Teresa Santos (Spain) Reyhan Küçükkaya (Istanbul, Turkey) Turgut Ulutin (Turkey) INTERNATIONAL ADVISORY COMMITTEE Members David Varon (Israel) Essam Aboelnazar (Egypt) Nejat Akar (Ankara, Turkey) Eugene V. Roitman (Russia) Juan José Badimon (USA) Faik Altıntaş (Istanbul, Turkey) Abdul Kareem Al Momen (Saudi Arabia) Henri Bounameaux (Switzerland) Birsen Ince (Istanbul, Turkey) Ivo Elezovic (Serbia) Benjamin Brenner (Israel) Kaan Kavaklı (Izmir, Turkey) Teresa Padró (Spain) Harry R. Büller (The Netherlands) Mehmet Kurtoğlu (Istanbul, Turkey) Marco Cattaneo (Italy) Şermin Tetik (Istanbul, Turkey) LOCAL ORGANIZING COMMITTEE S. Coccheri (Italy) Gül Öngen (Istanbul, Turkey) Cafer Adıgüzel (Istanbul, Turkey) Ola E. Dahl (Norway) Zeki Öngen (Istanbul, Turkey) Can Balkan (Izmir, Turkey) Bjorn Dahlback (Sweden) Ergül Berber (Istanbul, Turkey) Ismaïl Elalamy (France) EUROPEAN AND MEDITERRANEAN LEAGUE M. Cem Ar (Istanbul, Turkey) Jawed Fareed (USA) AGAINST THROMBOTIC DISEASES Veysel Sabri Hançer (Istanbul, Turkey) Andreas Greinacher (Germany) President Zühre Kaya (Ankara, Turkey) David A. Lane (United Kingdom) Lina Badimon (Spain) Ilhan Onaran (Istanbul, Turkey) Marcel Levi (The Netherlands) President: Former President Gülnihal Özdemir (Istanbul, Turkey) Christos Liapis (Greece) Jean-François Schved (France) Elif Uğur Ümit (Edirne, Turkey) Gregory YH Lip (United Kingdom) Jose Lopez (USA) General Secretary María Teresa Santos (Spain) NATIONAL ADVISORY COMMITTEES Abdul Kareem Al Momen (Saudi Arabia) Members Bülent Antmen (Adana, Turkey) Nevine Kassim (Egypt) Ismaïl Elalamy (France) Zafer Başlar (Istanbul, Turkey) Nigel Key (USA) Paolo Prandoni (Italy) Cengiz Beyan (Ankara, Turkey) Pier Mannucci (Italy) David Varon (Israel) Ali Zahit Bolaman (Aydın, Turkey) Claire McLintock (USA) Kürşat Bozkurt (Istanbul, Turkey) Danijela Mikovic (SERBIA) COUNTRY COUNCILORS Tiraje Celkan (Istanbul, Turkey) Joao Morais (Portugal) Cherif Abdelkhirane (Morocco) Cansun Demir (Istanbul, Turkey) James Morrissey (USA) Mehmet Nejat Akar (Turkey) Fatih Demirkan (Izmir, Turkey) Lina Badimon (Spain) Yeşim Erbil (Istanbul, Turkey) Ana Bronic (Croatia) Bülent Erdemli (Ankara, Turkey) Manuel Campos (Portugal) Nil Güler (Samsun, Turkey) Jean-François Schved (France) Ibrahim C. Haznedaroğlu (Ankara, Turkey) Luis Manuel Cunha-Ribeiro (Portugal) Necip Ilhan (Elazığ, Turkey) Maria Benedetta Donati (Italy) Ismaïl Elalamy (France) Sami Guermazi (Tunisia) Antonios Hatzizacharias (Greece) Nevine Kassim (Egypt) Andrew Nicolaides (Cyprus) Paolo Prandoni (Italy) Uri Seligsohn (Israel) Matija Kozak (Slovenia) 4 D T L M E Nil Molinas (Istanbul, Turkey) Hale Ören (Izmir, Turkey) Gülsüm Özet (Ankara, Turkey) Fahir Özkalemkaş (Bursa, Turkey) Mehmet Sönmez (Trabzon, Turkey) Teoman Soysal (Istanbul, Turkey) Mahmut Tobü (Izmir, Turkey) Lale Tokgözoğlu (Ankara, Turkey) Levent Ündar (Antalya, Turkey) Per Morten Sandset (Sweden) Yukio Ozaki (Japan) Paolo Prandoni (Italy) P H Reitsma (The Netherlands) Suely Meireles Rezende (Brazil) Frits Rosendaal (The Netherlands) M.T. Santos (Spain) Jean-François Schved (France) Matija Kozak (Slovenia) Svetlana M Strukova (Russia) Ali Taher (Lebanon) David Varon (Israel) Jaenine Walenga (USA) Steve Watson (United Kingdom) Jeffrey Weitz (Canada) SPEAKERS Mehmet Nejat Akar TOBB, Turkey Henri Bounameaux University of Geneva, Switzerland David Varon Hadassah-Hebrew University Medical Center, Israel Hasan Yazıcı University of Istanbul, Turkey Maria Graciela Pedreira Hospital de Clínicas Udelar, Uruguay Ingrid Pabinger Medical University of Vienna, Austria Zeki Ongen Istanbul University, Turkey María Teresa Santos University Hospital La Fe, Spain Joan Montaner Villalonga VHIR, Spain Ali Al-Hakim FDA, USA Charles Marc Samama Cochin University Hospital, France Yesim Dargaud Hôpital Cardiologique Louis Pradel, France Pier Mannuccio Mannucci IRCCS, Italy Nigel Key UNC Hemophilia & Thrombosis Center, USA Christos D. Liapis Athens University Medical School, Greece Lina Badimon CSIC-ICCC, Spain Raffaele de Caterina Institute of Cardiology, Italy Ismael Elalamy Hôpitaux Universitaires Paris, France Athanasios D. Giannoukas University Hospital of Larissa, Greece Igor Bokarev I. M. Sechenov First Moscow State Medical University, Russia Maria Benedetta Donati Department of Epidemiology and Prevention, Italy Mehmet Hamdi Kurtoğlu University of Istanbul, Turkey Jean-François Schved CHU Hospital, France Reyhan Kucukkaya Istanbul Bilim Universitesi, Turkey Hugo Ten Cate Maastricht University Medical Center, The Netherlands Ola E. Dahl Innlandet Hospital Trust and Thrombosis Research Institute, Norway Muhlis Cem Ar Istanbul University, Turkey John H. Griffin The Scripps Research Institute, USA Bagirath Gangadharam Baxalta Innovations GmbH, Austria Antonio Moscardó University Hospital La Fe, Spain Mehmet Ali Özcan Dokuz Eylül University, Turkey Jawed Fareed Loyola University Chicago, USA Yiming Yao Ronnsi Pharma Co Ltd., JiangSu, China Shaker Mousa The Pharmaceutical Research Institute at Albany, Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA Teresa Padró CSIC-ICCC, IIBSantPau, Spain Uluc Yis Dokuz Eylul University, Turkey Sule Unal Hacettepe University, Turkey T L M Doruk Erkan Hospital for Special Surgery, USA Essam Aboelnazar UQU University, Saudi Arabia Emmanuel Favaloro Institute of Clinical Pathology and Medical Research, ICPMR, Australia E Peter Brønnum Nielsen Aalborg University, Denmark Oktay Ozdemir Yorum Health Consulting Ltd., Turkey Gemma Vilahur CSIC-ICCC, IIBSantPau, Spain Thomas Renné Karolinska Institute and Universitz Hospital, Sweden Aysegul Ünüvar Istanbul University, Turkey Can Balkan Istanbul University, Turkey Vanessa Roldán Hospital Universitario Morales Meseguer, Spain Muhlis Cem Ar Cerrahpaşa University, Turkey Mustafa Nuri Yenerel Istanbul University, Turkey Mehmet Ali Özcan Dokuz Eylül University, Turkey Massimo Iacobelli Consultant on Pharmaceutical Strategic Planning and Development, Loyola University Chicago, Chicago, USA Frits Rosendaal University Medical Center, The Netherlands Mohammad Faranoush Hematologist and Oncologist, Iran University of Medical Sciences, Tehran, Iran Ergul Berber Arel University, Istanbul Danijela Mikovic Blood Transfusion Institute of Serbia Paolo Prandoni University of Padova, Italy Lorenzo Montrasio AIFA, Italy Marcel M. Levi University of Amsterdam, The Netherlands Johannes Thaler Medical University of Vienna, Austria Kaan Kavakli Ege University, Turkey Inam Hussain Consultant Hemostasis Reasearch Lavoratory, Loyola University, USA Evi Kabdiki Ealing Hospital, London, England Nilgün Sayinalp Hacettepe University, Ankara, Turkey İpek Kıvılcım Oğuzülgen Gazi University School of Medicine, Ankara, Turkey 5 CHAIRMEN Ahmet Muzaffer Demir Trakya University, Edirne, Turkey Lina Badimon Cardiovascular Research Center, CSIC-ICCC. Barcelona, Spain Sengun Ulutin Mehmet Hamdi Kurtoglu Istanbul University, Turkey Shaker Mousa The Pharmaceutical Research Institute at Albany, Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA Zeki Öngen Istanbul University, Turkey Jacqueline Conard Hotel-Dieu, Paris, France Charles Marc Samama Cochin University Hospital, Paris, France Vicente Vicente Centro Hemodonación, Murcia, Spain María Teresa Santos University Hospital La Fe, Valencia, Spain Nevine Kassim Ain Shams University, Faculty of Medicine. Heliopolis, Cairo. Egypt Erdal Aslım Acıbadem Hospital, Istanbul,Turkey Mehmet Ağırbaşlı Medeniyet University, Turkey Hasan Yazıcı Istanbul University, Turkey Evgeny Roitman Pigorov Russian National Research Medical University, Russia Meliha Nalcacı Istanbul University, Turkey Birsen Ince Istanbul University, Turkey Faik Altıntaş Yeditepe University, Turkey Cafer Adiguzel Medical Parc Hospital, Istanbul, Turkey Yeşim Erbil University of Istanbul, Turkey Osman Bülent Zülfikar Istanbul University, Turkey Kürsat Bozkurt Istanbul University, Turkey Gül Öngen Istanbul University, Turkey Lale Tokgözoglu Hacettepe University, Turkey Nilgün Sayınalp Hacettepe University, Ankara, Turkey Alexandros Tselepis University of Ioannina, Greece Ali Al Hakim FDA, USA Tazi Mezalek Zoubida Ibn Sina Hospital, Morocco Mahmut Töbü Ege University, Turkey Mustafa Nuri Yenerel Istanbul University, Turkey Marco Guerrini Istituo di Ricerche Chimiche e Bio chimiche 6-Ronzoni, Italy Sergio Coccheri University of Bologna, Italy Kaan Kavakli Ege University Children Hospital, Turkey Turgut Ulutin Istanbul University, Turkey María Graciela Pedreira Hospital de Clínicas Udelar, Uruguay Jawed Fareed Loyola University Chicago, USA Nehmet Nejat Akar TOBB, Turkey Zafer Baslar Istanbul University, Turkey Tulin Tiraje Celkan Cerrahpasa Medical Faculty, Istanbul, Turkey Ana Bronic Traumatology Clinic, Clinical Hospital Centre “Sestre Milosrdnice”, Zagreb, Croatia D T L M E Lorenzo Montrasio AIFA, Italy Grigoris Gerotziafas Hôpitaux Universitaires Est Parisien, Faculté de médecine Pierre et Marie Curie, Université Paris VI. France Ayşegül Ünüvar Istanbul University, Turkey Nigel Key UNC Hemophilia & Thrombosis Center, USA Emin Kansu ISH Chair of Council, Turkey 6 Abdulkareem Mohammed Almomen College of Medicine & KKUH, King Saud University, Saudi Arabia Hale Ören Dokuz Eylül University, Izmir, Turkey Paolo Prandoni Clinica Medica 2, University of Padova, Italy SCIENTIFIC PROGRAMME T L M E 7 WEDNESDAY, MAY 4 2016 Eyüp Auditorium 12:00 - 18:00 Registration 14:00 - 15:00 Opening Lectures. Prof. Dr. Orhan N. Ulutin Session I Chairs: Ahmet Muzaffer Demir (Turkey), Lina Badimon (Spain) 14:00 14:30 Discovery of FV Leiden Mutation in Urartu Ruins (BC 1000) in Van- Turkey Mehmet Nejat Akar (TOBB, Turkey) 14:30 15:00 Behçet’s Disease, Vascular Complications and Thrombosis Hasan Yazıcı (University of Istanbul, Turkey) 15:00 - 15:30 Coffee Break 15:30 - 17:00 Opening Lectures. Prof. Dr. Orhan N. Ulutin Session II Chairs: Sengun Ulutin (Turkey), Emin Kansu (Turkey), Jawed Fareed (USA) 15:30 16:00 Stroke and Bleeding Risk Stratification in Atrial Fibrilation: from Guidelines to Clinical Practice Zeki Ongen (Istanbul University, Turkey) 16:00 16:30 Heparin Centennial. A Century of scientific and clinical progress Jawed Fareed 16:3017:00 Aging is a Global Problem: Focus on Thrombosis and Haemostasis Pier Mannuccio Mannucci (IRCCS, Italy) 17:00 - 18:00 8 Satellite Symposia Essentials and New Approaches in Hemophilia B Treatment Chair: Ayşegül Ünüvar, (Turkey) 17:00 17:30 Physiology of FIX and Bleeding Pattern Pier Mannuccio Mannucci, Italy 17:30 18:00 Switch to BeneFIX from pdFIX Products and Once Weekly Prophylactic Treatment Kaan Kavaklı, Turkey 18:00 - 18:15 Opening Ceremony Chairs: Lina Badimon (Spain), Ahmet Muzaffer Demir, (Turkey) 18:15 - 19:15 Dance Show Polyphonic Chorus M E D T L THURSDAY, MAY 5 2016 08:30 - 09:30 Fener Auditorium Eyüp Auditorium Prof. Dr. Meyer-Michel Samama Session. Heparin Induced Thrombocytopenia Chairs: Jacqueline Conard( France) Prof. Dr. Jose Antonio Iriarte Session. Atherosclerosis and Risk Factors Chairs: Vicente Vicente (Spain), María Teresa Santos (Spain) Current Concepts in atherosclerosis and its risk factors Lina Badimon (CSIC-ICCC, Spain) 08:30 09:00 Pharmacology of Heparins and Heparinomimetics Jawed Fareed, (Loyola University Chicago, USA) 09:00 09:30 Pathogenesis and Treatment of HIT in 2016 Grigoris T Gerotziafas (Hôpitaux Universitaires Paris, France) 09:40 - 10:40 Oral Communications Eyüp Auditorium Fener Auditorium OC-1-TH OC-3-TH OC-1-TH VENOUS THROMBOEMBOLISM (Eyüp Auditorium) Chairs: Paolo Prandoni (Italy), Mahmut Töbü (Turkey) C-0057 HIGH PREVALENCE OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR SYNCOPE Paolo Prandoni, Anthonie Wa Lensing, Martin H Prins, Maurizio Ciammaichella, Marica Perlati, Nicola Mumoli, Eugenio Bucherini, Adriana Visonà, Carlo Bova, Davide Imberti, Stefano Campostrini, Sofia Barbar C-0083 INCIDENCE OF HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLIC DISEASE AMONG CLINICAL AND SURGICAL INPATIENTS Maria Lourdes Posadas-Martinez, María Florencia Grande-Ratti, Jimena Vicens, Fernán González Bernaldo De Quirós, Fernando Javier Vázquez, Diego Giunta C-0110 EFFECTS OF INFERIOR VENA CAVA FILTER IN PATIENTS WITH THROMBOEMBOLIC RECURRENCES ON ANTICOAGULANT THERAPY Meritxell Mellado Joan, José Ignacio Pijoan, David Jiménez, Alfonso Muriel, Drahomir Aujesky, Laurent Bertoletti, Herve Decousus, Silvy Laporte, Albert Clará, Roger Yusen, Manel Monreal, Riete Investigators C-0324 ANALYSIS OF HEPARIN INDUCED THROMBOCYTOPENIA SCREENING TESTS IN CRITICAL CARE UNITS AT KING FAISAL SPECIALIZED HOSPITAL AND RESEARCH CENTER M.G. Jamil, Osamah Khojah, K. Maghrabi, S. Barri, N. Salahuddin, R. Amin, I. Khoja, T. Owaidah C-0058 A PROSPECTIVE ALGORITHM INCORPORATING LIMITED AND WHOLE-LEG ASSESSMENT OF THE DEEP VENOUS SYSTEM IN SYMPTOMATIC OUTPATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (THE PALLADIO STUDY) Walter Ageno, Giuseppe Camporese, Nicoletta Riva, Matteo Iotti, Eugenio Bucherini, Marc Righini, Pieter Kamphuisen, Peter Verhamme, James Douketis, Chiara Tonello, Paolo Prandoni C-0245 GUIDELINE ADHERENCE OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANT THERAPY : RESULTS FROM RAMSES STUDY Ozcan Basaran, Volkan Dogan, Murat Biteker, Osman Beton, Mehmet Tekinalp, Ismail Bolat, Onur Tasar, Macit Kalcik, Ezgi Kalaycioglu, Ahmet Cagri Aykan, Ozgen Safak, Mehmet Yaman, Sinan Inci, Bernas Altintas, Sedat Kalkan, Fatma Karadeniz, Ibrahim Altun, Mustafa Ozcan Soylu T L M E OC-3-TH DIAGNOSTIC AND LABORATORY METHODS (Fener Auditorium) Chairs: Yesim Dargaud, Turkey; Alexandros Tselepis, (Greece) C-0333 SENSITIVITY OF LOCAL DRVTT SCREEN AND CONFIRM REAGENTS TO RIVAROXABAN AND APIXABAN Desiree Coen Herak C-0374 DIFFERENCES IN THROMBIN GENERATION MARKERS AT BASELINE IN PATIENTS WITH SEPSIS ASSOCIATED COAGULOPATHIES Debra Hoppensteadt, Amanda Walborn, Daniel Kahn, Mark Williams, Jawed Fareed C-0153 EVALUATION OF THROMBOELASTOGRAPHY (TEG) IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM: PLATELET COUNT >600 (X109/L) ASSOCIATED WITH PROTHROMBOTIC PARAMETERS Cheryl Ng, Carole Smith, Lachlan Hayes, Andrew Grigg, Harshal Nandurkar, Prahlad Ho 9 10:40 - 11:15 C-0343 DOXORUBICIN-INDUCED MDR1/P-GP IN MCF7 BREAST CANCER CELLS WAS ASSOCIATED WITH TISSUE FACTOR OVEREXPRESSION AND THROMBIN GENERATION Khaterchi Amir, Karroum Asma, Mbemba Elisabeth, Rousseau Aurelie, Van Dreden Patrick, Gkalea Vassiliki, Elalamy Ismail, Hatmi Mohamed, Gerotziafas Grigorios C-0350 ASSESSEMENT OF QUALITY OF ANTICOAGULATION WITH VKA IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME Helena Cruz Gomes, Fátima Correia, Luciana Gonçalves, Carla Monteiro, Manuela Carvalho, Beatriz Delgado, Carmo Koch, Graça Oliveira C-0136 EXOSOMAL MICRORNA SIGNATURE PREDICTS FUTURE ISCHEMIC EVENTS IN HIGH CARDIOVASCULAR RISK PATIENTS Rosa Suades, Teresa Padro, Sandra Camino, Rodrigo Alonso, Pedro Mata, Lina Badimon Poster Viewing - Coffee Break 11:15 - 12:45 Educational Symposium. Bleeding Disorders and Thrombosis Chairs: Nevine Kassim (Egypt), Osman Bülent Zülfikar (Turkey) Educational Symposium. New Insights in Haemostasis Chairs: Ahmet Muzaffer Demir (Turkey), Gül Öngen (Turkey) 11:15 11:45 Aging Problems in Adult Hemophilia Jean-François Schved (CHU Hospital, France) Thrombin, Thrombomodulin and TAFI in the Molecular Link between Coagulation and Fibrinolysis Hugo Ten Cate (Maastricht University Medical Center, The Netherlands) 11:45 12:15 Management of Thrombotic Events in Patients with Congenital Bleeding Diseases Muhlis Cem Ar (Istanbul University, Turkey) New Insights in the Role of Protein C System in Hemostatic and Non-Hemostatic Functions John H. Griffin (The Scripps Research Institute, USA) 12:15 12:45 Inhibitor issues in Hemophilia: Bench to Bedside Bagirath Gangadharam (Baxalta Innovations GmbH, Austria) Acetylation of Proteins in Platelets, a new Signal Transduction Mechanism Antonio Moscardó (University Hospital La Fe, Spain) 13:00 - 14:00 Satellite Symposia Fener Auditorium Eyüp Auditorium Satellite Simposium Chair: Nilgün Sayınalp (Turkey) INTERNATIONAL UNION ANGIOLOGY Revolade at Focus: Management of Adult Chronic ITP Cases. Mehmet Ali Özcan (Dokuz Eylül University, Turkey) Satellite Simposium Development on non-porcine heparins with a focus on sheep heparins Chairs: Marco Guerrini (Italy), Ali Al Hakim (USA) Rationale for the Development of Sheep Heparins Biosimilar to Porcine Heparins Jawed Fareed, (Loyola University Chicago, USA) Feasibility for the Production of the Biosimilar Sheep Heparin for Clinical Usage Yiming Yao, (Ronnsi Pharma Co Ltd., JiangSu, China) D T L Why do we Need to Develop Heparins from Non-porcine Origin? Shaker Mousa, (The Pharmaceutical Research Institute at Albany, Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA) Invited Commentary / Discussion Inam Hussain (Consultant, Hemostasis Research Laboratory, Loyola University Chicago, USA) and Evi Kalodiki (Ealing Hospital, London, England) 10 M E 14:15 - 15:45 Educational Symposium. Thrombotic Microangiopathies Chairs: Kaan Kavakli (Turkey), Abdulkareem Mohammed Almomen (Saudi Arabia) Educational Symposium. Current Concepts of VTE Chairs: Mehmet Hamdi Kurtoglu (Turkey), Mehmet Hamdi Kurtoglu (Turkey) 14:15 14:45 Atypical Hemolytic Uremic Syndrome: from Molecular Abnormalities to Clinical Issues Pier Mannuccio Mannucci (IRCCS, Italy) New Insights in Genomics of Thrombosis Frits Rosendaal (University Medical Center, The Netherlands) 14:45 15:15 Thrombotic Microangiopathies: How ADAMTS13 controls VWF Function Ergul Berber (Arel University, Turkey) New Perspectives on Pathophysiology and Management of the Post-Thrombotic Syndrome Paolo Prandoni (University of Padova, Italy) 15:15 15:45 New Insights on Physiopathology of DIC Marcel M. Levi (University of Amsterdam, The Netherlands) Optimal Long-Term Treatment of Patients with Unprovoked VTE Henri Bounameaux (University of Geneva, Switzerland) 15:45 - 16:15 Poster Viewing 16:15 - 17:45 JOINT SYMPOSIUM MLTD/ISTH/CLATH: Focus on Antithrombotic Treatment Chairs: Nigel Key (USA), María Teresa Santos (Spain), María Graciela Pedreira (Uruguay) Educational Symposium. Antithrombotic Treatment Chairs: Zeki Öngen (Turkey), Emre Tekgündüz (Turkey) 16:15 16:45 The forgotten and complex study of fibrinolytic system María Graciela Pedreira (Hospital de Clínicas Udelar, Uruguay) An Update on New Anticoagulants İpek Kıvılcım Ogüzülgen (Gazi University, Turkey) 16:45 17:15 The role of aspirin in the context of dual antiplatelet treatment in patients with acute myocardial infarction María Teresa Santos (University Hospital La Fe, Spain) Reversal of Direct Oral Anticoagulants Grigoris T Gerotziafas, (Hôpitaux Universitaires Paris, France) 17:15 17:45 Rationale for targeting factors XI and XII with novel anticoagulant approaches Nigel Key (UNC Hemophilia & Thrombosis Center, USA) Dual or triple antithrombotic treatment in coronary artery disease Raffaele de Caterina (Institute of Cardiology, Italy) 17:45 - 18:15 Poster Viewing 18:00 - 19:00 Debate Session. Thrombolysis in DVT Chairs: Erdal Aslım (Turkey) 18:15 - 19:45 T L M YES Athanasios D. Giannoukas (University Hospital of Larissa, Greece) NO Mehmet Hamdi Kurtoglu (University of Istanbul, Turkey) EMLTD Councilor’s’ and Board’s Meeting and EMLTD General Assembly E 11 FRIDAY, MAY 6 2016 08:30 - 09:30 Fener Auditorium Eyüp Auditorium State of the Art Session. Autoimmune Thrombohemorragic Disorders Chairs: Hasan Yazıcı (Turkey) Meliha Nalcacı (Turkey) Educational Symposium VTE in Surgery Chairs: Faik Altıntaş (Turkey) Yeşim Erbil (Turkey) 08:30 09:30 Immune Thrombocytopenia in 2016. Reyhan Kucukkaya (Sisli Florence Nightingale Hospital, Turkey) Systemic Thromboembolism, Organ Dysfunction and Fatalities Following Trauma and Major Surgery: A new Protective Strategy. Ola E. Dahl (Innlandet Hospital Trust and Thrombosis Research Institute, Norway) 09:00 09:30 New Insights in Antiphospholipid Syndrome. Doruk Erkan (Hospital for Special Surgery, USA) Thromboembolism and prophylaxis in mini-invasive surgery Essam Aboelnazar (UQU University, Saudi Arabia) 09:40 - 10:40 Oral Communications Eyüp Auditorium Tophane Auditorium Fener Auditorium OC-4-TH OC-5-TH OC-6-TH OC-4-TH ANTICOAGULANT DRUGS (Eyüp Auditorium) Chairs: Jacqueline Conard (France), Vicente Vicente (Spain) C-0201 CLINICAL PERSPECTIVES ON THE MANAGEMENT OF SEVERE BLEEDING IN PATIENTS TREATED WITH ORAL ANTICOAGULANTS IN SPAIN. RESULTS OF THE DECOVER STUDY (DELPHI IN ORAL ANTICOAGULATION AND ACTION REVERSAL) A. Martin, V. Roldán, J. Mateo, J.R. González-Porras, R. Lecumberri, B. Coll-Vinent, P. Marco, C. Suero, S. Soulard, C. Crespo, M. Camats, M. Pérez, Vicente Garcia C-0377 IDARUCIZAMAB, A SPECIFIC ANTIDOTE FOR DABIGATRAN, CROSS-REACTS WITH MELAGATRAN AND MAY ALSO INTERACT WITH OTHER BENZAMIDINE-CONTAINING COMPOUNDS Jawed Fareed, Amanda Walborn, Debra Hoppensteadt, Jeanine Walenga, Eduardo Ramacciotti, S. Abro, Walter Jeske, Olivia Bouchard, Ismail Elalmay C-0327 DIRECT FACTOR XA INHIBITORS FOR PULMONARY EMBOLISM IN PATIENTS INITIALLY ADMITTED TO SUB INTENSIVE CARE UNIT FOR INTERMEDIATE HIGH RISK INDEX EVENT Dimitriy Arioli, Monica Casella, Maria Cristina Leone, Giovanni Tortorella, Matteo Azzarone, Massimo Calzolari, Lorenzo Morini, Francesca Pileri, Elisa Romagnoli, Angela Muoio, Maria Granito, Attilia Maria Pizzini, Annamaria Casali, Emanuele Negri C-0258 INVESTIGATION OF THE ANTITHROMBOTIC AND ANTIPLATELET EFFECT OF A NEW UREA ANALOG, ON CAROTID ARTERY THROMBOSIS IN RABBITS Styliani Papadaki, Iraklis Moschonas, Michail Peroulis, Prokopia Tatsidou, Antonia Sarantou, Constantinos Tellis, George Varvounis, Alexandros Tselepis C-0368 MULTILOCUS GENETIC RISK SCORE: A NEW METHODOLOGY FOR THE EVALUATION OF THE RISK FOR IDIOPATHIC VENOUS THROMBOEMBOLISM G.T. Gerotziafas, Celine Delassassegne, Virgine Planche, Ismail Elalamy C-0092 DIFFERENTIAL PLATELET ACTIVATION AFTER P2Y12 INHIBITION Leunissen Tesse Charlotte, Wisman Peter Paul, Van Holten Thijs, De Groot Philip, Remijn Jasper, Frans Moll, De Borst Gert Jan, Teraa Martin, Verhaar Marianne, Urbanus Rolf, Roest Mark D T L OC-5-TH ANTITHROMBOTIC DRUGS / CEREBRAL THROMBOSIS (Tophane Auditorium) Chairs: María Graciela Pedreira (Uruguay), Joan Montaner Villalonga, (Spain) 12 C-0365 BRANDED AND COPIES OF THE LOW MOLECULAR WEIGHT ENOXAPARIN; ARE THEY SAME? Grigoris T Gerotziafas, Aurèlie Rousseau, Elisabeth Mbemba, Amir Khartechi, Patrick Van Dreden, Janine Walenga, Annette Larsen, Jawed Fareed, Ismail Elalamy C-0176 A MULTINATIONAL, MULTICENTRE, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP STUDY ON THE EFFICACY AND SAFETY OF ONCE DAILY BEMIPARIN COMPARED TO TWICE DAILY ENOXAPARIN IN THE TREATMENT OF ACUTE DEEP VEIN THROMBOSIS Sebastian M. Schellong, Javier Martinez-Gonzalez, Igor Alexandrovich Suchkov, Michela Falciani, Maria Theresia Kaltwasser C-0177 ASSESSMENT OF BLEEDING RISK IN ELDERLY AND PATIENTS WITH RENAL IMPAIRMENT UNDER BEMIPARIN PROPHYLACTIC DOSES FOR MORE THAN 3 WEEKS Javier Martinez-Gonzalez, Ignacio Ayani C-0204 SURFACE EXPRESSION OF TYRO3, AXL AND MER RECEPTORS ON PLATELETS IN PATIENTS WITH TYPE 2 DIABETES Fikriye Uras, Husniye Dagdeviren, Derya Ozsavci, Ozlem Bingol Ozakpinar, Gulderen Yanikkaya Demirel, Hasan Aydin, Sami Karti M E C-0224 TOLERABILITY AND EFFICACY OF ELTROMBOPAG IN CHRONIC IMMUNE-MEDIATED THROMBOCYTOPENIA: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Ahmed Elgebaly, Gehad El Ashal, Ahmed Menshawy, Mohamed Elfil C-0358 PLATELET HEAT SHOCK PROTEIN 70 (HSP70) IS A REGULATOR OF PLATELET INTEGRIN ACTIVATION, GRANULE SECRETION AND AGGREGATION Rachel Rigg, Laura D. Healy, Marie S. Nowak, Jérémy Mallet, Marisa L. D. Thierheimer, Jiaqing Pang, Owen J. T. Mccarty, Joseph E. Aslan OC-6-TH PREGNANCY AND THROMBOSIS / DVT AND PE (Fener Auditorium) Chairs: Nil Güler, Turkey; Fikriye Uras, Turkey 10:40 - 11:15 C-0336 PREGNANCY IN HIGH RISK ANTITHROMBIN DEFICIENCY: PREVENTION OF VENOUS THROMBOEMBOLISM WITH THE LMW HEPARIN PROPHYLAXIS REGIMENS USED IN NORDIC COUNTRIES Ingunn Dybedal, Anne Mette Hvas, Rosa Chiarete, Anne Flem Jacobsen, Per Morten Sandset, Harald Weedon-Fekjar, Katarina Bremme, Ulrich Abildgaard C-0060 THE IMPACT OF RESIDUAL OBSTRUCTION ON THE LONG-TERM OUTCOME OF PATIENTS WITH PULMONARY EMBOLISM Raffaele Pesavento, Lucia Filippi, Antonio Palla, Anna Chiara Frigo, Adriana Visonà, Carlo Bova, Stefano Cuppini, Ferdinando Porro, Sabina Villalta, Maurizio Ciammaichella, Eugenio Bucherini, Giovanni Nante, Stefano Battistelli, Giampietro Beltramello, Domenico Prisco, Paolo Prandoni C-0084 CLINICAL COURSE OF PATIENTS WITH VENOUS THROMBOEMBOLISM (VTE) AND INFERIOR VENA CAVA FILTER (IVCF): COHORT STUDY Maria Lourdes Posadas-Martinez, María Florencia Grande-Ratti, Paula Gutiérrez, Fernán González Bernaldo De Quirós, Diego Hernán Giunta, Fernando Javier Vázquez C-0143 VENOUS THROMBOEMBOLISM IN WOMEN USING HORMONAL CONTRACEPTION. FINDINGS FROM A SINGLE CENTER Alba Sara Vilches Moreno, Alejandra Latorre González, Miriam Vilches Moreno, Begoña Fernández Jiménez, Jacobina Cachá Acosta, María Jesús Gómez Vázquez C-0261 USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY Demet Cekdemir, Fusun Ozdemirkiran, Serkan Guvenc, Ali Eser, Vildan Ozkocaman, Handan Haydaroglu Sahin, Esra Ermis Turak, Erdal Kara, Melda Comert, Sevil Sadri, Muzeyyen Aslaner, Bahar Uncu Ulu, Abdullah Karakus, Derya Selim Bapur, Demet Aydin, Inci Alacacioglu, Atakan Tekinalp, Sinem Namdaroglu, Funda Ceran, Pinar Tarkun, Demet Kiper, Mustafa Cetiner, Mustafa Yenerel, Elif Gulsum Umit, Guven Yilmaz, Hatice Terzi, Erden Atilla, Umit Yavuz Malkan, Kadir Acar, Erman Ozturk, Anil Tombak, Cenk Sunu, Ozan Salim, Nevin Alayvaz, Ozkan Sayan, Ulku Ozan, Mesut Ayer, Zafer Gokgoz, Neslihan Andic, Ebru Kizilkilic, Figen Noyan, Mehmet Ozen, Funda Pepedil Tanrikulu, Guchan Alanoglu, Hasan Atilla Ozkan, Vahap Aslan, Guven Cetin, Alev Akyol Erikci, Burak Deveci, Fadime Ersoy Dursun, Hasan Dermenci, Olga Meltem Akay Yanar, Duzgun Ozatli, Levent Undar, Eyup Naci Tiftik, Ayhan Gulsan Turkoz Sucak, Ibrahim Haznedaroglu, Muhit Ozcan, Mehmet Sencan, Ahmet Muzaffer Demir, Murat Tombuloglu, Gulsum Ozet, Oktay Bilgir, Burhan Turgut, Mehmet Ali Ozcan, Kadriye Bahriye Payzin, Mehmet Sonmez, Orhan Ayyildiz, Mehmet Sinan Dal, Sehmus Ertop, Teoman Soysal, Emin Kaya, Ramazan Eser, Ali Unal, Mustafa Pehlivan, Tulin Tuglular Firatli, Guray Saydam, Reyhan Diz Kucukkaya C-0229 DESIGN AND APPLICATION OF A TWENTY-THREE-GENE PANEL BY NEXT-GENERATION SEQUENCING FOR INHERITED COAGULATION BLEEDING DISORDERS. Jose Maria Bastida, Monica Del Rey, Kamila Janusz, Ana Hortal, Rocio Benito, Maria Eugenia Sarasquete, Maria Luisa Lozano, Elena Fontecha, Rosa Fisac, J. Javier Garcia Frade, Carlos Aguilar, M. Paz Martinez, Emilia Pardal, Carmen Aguilera, Jose Manuel Martin Antoran, Beatriz Perez, Nuria Bermejo, Rafael Ramos, Luz Angela Silvestre, Maria Jose Cebeiro, M. Rosa Cardesa, Jesus Maria Hernandez Sanchez, Miriam Lopez Parra, Julio Davila, Jesus Maria Hernandez Rivas, Jose Ramon Gonzalez Porras Poster Viewing - Coffee Break E Educational Symposium. Anticoagulation in Atrial Fibrilation Chairs: Kürsat Bozkurt (Turkey), 11:15 - 12:15 T L M 11:15 11:45 CHA2DS2-VASc Score=1: No Treatment, Aspirin or Oral Anticoagulation? Peter Brønnum Nielsen (Aalborg University, Denmark) 11:45 12:15 Do Vitamin K Antagonists (VKAs) still have a Role in the Management of AF? Vanessa Roldán (Hospital Universitario Morales Meseguer, Spain) 13 13:00 - 14:00 Satellite Symposia Fener Auditorium Eyüp Auditorium Tophane Auditorium Satellite Simposium Satellite Simposium Personalized Prophylaxis in Hemophilia Chair: Aysegül Ünüvar, Turkey The importance of personalizing treatment in Hemophilia Muhlis Cem Ar, (Turkey) New inside in Thrombotic Complications of PNH Chair: Mahmut Töbü, (Turkey) INTERNATIONAL UNION ANGIOLOGY Satellite Simposium Recombinant Coagulation Factors and their Biosimilar Counterparts. A Case of Factor VIIa in The Management of hemophilia with Inhibitors Chairs: Ahmet Muzaffer Demir (Turkey), Lorenzo Montrasio (Italy) The Clinical and diagnostic Appoach to PNH Mustafa Nuri Yenerel (Istanbul University, Turkey) Biosimilar Recombinant Proteins and the Current Regulatory Guidelines for Clinical Use Massimo Iacobelli (Consultant on Pharmaceutical Strategic Planning and Development, Loyola University Chicago, Chicago, USA) The role of pharmacokinetic dosing in personalized prophylaxis Can Balkan, (Turkey) Biosimilar Factor VIIa is Comparable to Branded Novoseven. Clinical Validation Jawed Fareed (Loyola University Chicago, Chicago, USA) Review of the Clinical Trials on a Biosimilar Recombinant Factor VIIa in Various Clinical Studies Mohammad Faranoush (Hematologist and Oncologist, Iran University of Medical Sciences, Tehran, Iran) 14:15 - 15:15 Educational Symposium Thrombotic and Bleeding Disorders in Women Chairs: Aysegül Ünüvar(Turkey), Gülnihal Özdemir (Turkey) Postpartum Hemorrhage in Carriers of Hemophilia and Women with VWD Danijela Mikovic (Blood Transfusion Institute of Serbia) 14:15 14:45 Biosimilar and Generic Drugs for the Management of Bleeding and Thrombosis Jawed Fareed (Loyola University, USA) 14:45 15:15 Regulatory Pathways for Biosimilar Coagulation Proteins or Regulatory pathways for Biologics Lorenzo Montrasio (AIFA, Italy) 15:15 - 15:45 Poster Viewing 15:45 - 17:15 Educational Symposium Cancer Associated Thrombosis Chairs: Turgut Ulutin (Turkey), Shaker Mousa (USA) Educational Symposium Antiplatelet Therapy Chair: Mehmet Ağırbaşlı (Turkey), Antonio Hatzizacharias (Greece) 15:45 16:15 Microvesicules as Mediators of Tumor Progression Johannes Thaler (Medical University of Vienna, Austria) Inhibition of Protease-Activated Receptors: New Insights in Antiplatelet Therapy David Varon (Hadassah-Hebrew University Medical Center, Israel) 16:15 16:45 The Role of Blood Cells in Cancer Associated Thrombosis Ingrid Pabinger (Medical University of Vienna, Austria) P2Y12 Receptor Blockers in Cardiovascular Disease: An Update Lina Badimon (CSIC-ICCC, Spain) 16:45 17:15 Prophylaxis and treatment of venous thromboembolism in patients with cancer Shaker Mousa (Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA) 17:15 - 18:15 14 State of the Art Session Biosimilars and Generics Issue on Thrombosis Chairs: Grigorios Gerotziafas (France) D T L State of the Art Session Cerebrovascular/Peripheral Arterial Diseases Chairs: Evgeny Roitman (Russia), Birsen Ince (Turkey) State of the Art Session The risk prediction and treatment of VTE Chairs: Cafer Adiguzel (Turkey), Mehmet Nejat Akar (Turkey) M E 17:15 17:45 The Pathophysiology of Ischemic Stroke: Focus on Biomarkers Joan Montaner Villalonga (VHIR, Spain) Risk prediction for VTE recurrency Yesim Dargaud (Hôpital Cardiologique Louis Pradel, France) 17:45 18:15 Clinical and Surgical Management of Patients with Peripheral Vascular Diseases Christos D. Liapis (Athens University Medical School, Greece) The treatment of Pulmonary embolism: Russian Perspective Igor Bokarev (I. M. Sechenov First Moscow State Medical University, Russia) SATURDAY, MAY 7 2016 08:30 - 09:30 MEYER-MICHEL SAMAMA HALL ORHAN N. ULUTIN HALL Fener Auditorium Eyüp Auditorium Young Investigator Session Chairs: Zafer Baslar (Turkey), Tulin Tiraje Celkan (Turkey) State of the Art Session. Thrombosis in Children Chairs: Hale Ören (Turkey) 08:30 09:00 Mouse Models of Venous Thrombosis. Teresa Padró (CSIC-ICCC, IIB Sant Pau, Spain) Thrombolytic Treatment in Pediatric Stroke. Uluc Yis (Dokuz Eylul University, Turkey) 09:00 09:30 Number needed to treat (NNT) and number needed to harm (NNH): What do they tell for clinicians? Oktay Ozdemir (Turkey) Hemostatic Alterations in Sickle Cell Syndrome. Sule Unal (Hacettepe University, Turkey) 09:40 - 10:40 Oral Communications Eyüp Auditorium Fener Auditorium OC-7-TH OC-9-TH OC-7-TH VTE IN CANCER / SURGERY (Eyüp Auditorium) Chairs: Shaker Mousa (USA), Sermin Tetik, Turkey C-0059 THE VALUE OF COMPUTED TOMOGRAPHY FOR THE DETECTION OF OCCULT CANCER IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM (D’ACQUAPENDENTE STUDY) Andrea Piccioli, Enrico Bernardi, Fabio Dalla Valle, Adriana Visonà, Pietro F Tropeano, Carlo Bova, Eugenio Bucherini, Paolo Prandoni C-0113 VENOUS THROMBOEMBOLISM PREVENTION IN ONCOLOGY PATIENTS WITH RADIATION THERAPY (VERT STUDY) Mikhail Cherkashin, Natalia Berezina, Nicolay Vorobyov, Alexey Mikhailov, Alexey Serov C-0371 FIBRINOLYTIC DYSREGULATION IN ARTHROPLASTY PATIENTS MAY CONTRIBUTE TO POSTOPERATIVE HEMOSTATIC COMPLICATIONS Nil Guler, Christopher Wanderling, Drew Burleson, Debra Hoppensteadt, Harold Rees, Jawed Fareed, William Hopkinson C-0299 CANCER PROCOAGULANTS PROMOTE TUMOR GROWTH AND ANGIOGENESIS IN BREAST CANCER PROGRESSION; AN IN VIVO BIOMARKER STUDY Sermin Tetik, Samet Ergun, Sadik Sahin, Nusret Erdogan C-0132 LOW PREVALENCE OF SYMPTOMATIC VENOUS THROMBOEMBOLISM FOLLOWING RENAL TRANSPLANTATION Ana Virginia Figueroa Córdoba, Danilo Musso, Gabriela Robaina, Gustavo D. Martini, Ricardo Arturo Albertini, Carlos Chiurchiu, Aldo Hugo Tabares C-0125 INCREASED PLATELET ACTIVATION AND P-SELECTIN IN OBSTRUCTIVE SLEEP APNEA SYNDROME Cigdem Bayram Gurel, Engin Korkmaz, Suzan Adn Çnar, Gülsel Ayaz, Gönül Kangür, Günnur Deniz, Turgut Ulutin, Bülent Tutluolu T L M E C-TH-9 ANTITHROMBOTIC DRUGS / ARTERIAL THROMBOSIS AND ATHEROSCLEROSIS / ATRIAL FIBRILLATION (Fener Auditorium) Chairs: Ayşen Yarat (Turkey), Antonio Moscardó (Spain) 10:40 - 11:15 C-0263 NEUTROPHIL EXTRACELULAR TRAPS IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME ARE ASSOCIATED WITH MARKERS OF PLATELET ACTIVATION Ana Latorre, María Ferré, Maria Paz Fuset, Elena Sánchez, Isabel Madrid, Juana Vallés, Antonio Salvador, Maria Teresa Santos, Antonio Moscardó C-0189 CORONARY THROMBUS CHARACTERIZATION: NATIVE CORONARY THROMBOSIS AND IN-STENT THROMBOSIS Judit Cubedo, Rosa Suades, Javier Goicolea, Teresa Padró, Ana Blasco, Lina Badimon C-0141 THROMBIN-INDUCED PLATELET ACTIVATION AND MICROVESICLE RELEASE: PROTEOMIC SIGNATURE OF PLATELET-DERIVED MICROVESICLES Rosa Suades, Teresa Padro, Estefania Segales, Lina Badimon C-0037 EXOPOLYPHOSPHATASE BASED STRATEGIES FOR INTERFERENCE WITH PROCOAGULANT POLYPHOSPHATE ACTIVITIES Linda Labberton, Thomas Renné Poster Viewing - Coffee Break 15 11:15 - 12:45 Presidential Farewell Symposium. Crosslink between Inflamation and Thrombosis Chairs: Lina Badimon (Spain), Ahmet Muzaffer Demir (Turkey), Paolo Prandoni (Italy) 11:15 11:45 NETosis and Innate Immunity: Focus on Thrombosis Gemma Vilahur (CSIC-ICCC, IIBSantPau, Spain) 11:45 12:15 Polyphosphates and Contact Factors: Links among Coagulation, Platelets and Inflammation Thomas Renné (Karolinska Institute and Universitz Hospital) 12:15 12:45 Circulating Non-Coding RNAs as Active Contributors in Thrombosis Teresa Padró (CSIC-ICCC, IIB Sant Pau, Spain) 12:45 – 13:00 Closing Session D T L 16 M E POSTERS Animal, cellular and molecular research in thrombosis P-0052 DIFFERENTIATION OF ANTAGONISTS OF PROTEINASE ACTIVATED RECEPTOR 1 AND 4 IN NONHUMAN PRIMATE MODELS OF HEMOSTASIS AND ANTI-THROMBOSIS A Wickham, M Michener, L Handt, A Basso, S Fried, L Chu, M Maderia, K Owens, J Imbriglio, K Wang, J Metzger, Tian-Quan Cai Animal, cellular and molecular research in thrombosis P-0139 INFLUENCE OF ANTICOAGULANT THERAPY TYPE ON THE QUALITY OF LIFE IN PATIENTS WITH DEEP VENOUS THROMBOSIS Igor Suchkov, Roman Kalinin, Nina Mzhavanadze, Andrey Agapov P-0237 DOES TOPICAL APPLICATION OF TRANEXAMIC ACID DURING CARDIAC ELECTRONIC DEVICE IMPLANTATION AFFECT COAGULATION PROFILE? Osman Beton P-0239 THROMBOPROPHYLAXIS WITH RIVAROXABAN AFTER TOTAL HIP AND KNEE ARTHROPLASTY - OUR THREE YEARS EXPERIENCE Elena Ambarkova-Vilarova, George Zafirovski, Saso Mladenovski, Konstantin Mitev P-0101 ANTITHROMBOTIC AGENTS, RIVAROXABAN AND CILOSAZOL, PREVENT LUNG AND RENAL INJURY FOLLOWING ABDOMINAL AORTA ISCHEMIA / REPERFUSION IN A RAT MODEL Orhan Findik, Ahmet Tugrul Eruyar, Atike Tekeli Kunt, Seda Gulec Yilmaz, Selim Isbir, Hakan Parlar, Ozgur Baris, Canan Balci, Emre Murat Altinkilic, Selda Turkmen, Huseyin Kilili, Turgay Isbir P-0241 VITAMIN K DEFICIENCY DUE TO STRICT LOW VITAMIN K DIET IN PATIENTS WHO ARE ON LONG-TERM WARFARIN ANTICOAGULATION Abdulkareem Almomen Mohammed, Maher Khosayfan, Sayed Husseini, Sarah Arbab P-0103 AN ANTIPLATELET AGENT, CILOSTAZOL, ATTENUTATES MYOCARDIAL DAMAGE INDUCED BY ABDOMINAL AORTA ISCHEMIA / REPERFUSION IN A RAT MODEL Atike Tekeli Kunt, Orhan Findik, Seda Gulec Yilmaz, Ahmet Tugrul Eruyar, Hakan Parlar, Ozgur Baris, Canan Balci, Emre Murat Altinkilic, Selda Turkmen, Altay Burak Dalan, Hüseyin Ayhan, Selim Isbir, Turgay Isbir P-0340 EFFICIENCY OF DIRECT ORAL ANTICOAGULANTS ON ANTIPHOSPHOLIPID ANTIBODY SYNDROME: A CASE REPORT Muhammet Maden, Elif Gulsum Umit, Sule Erdogan, Ahmet Muzaffer Demir P-0350 ASSESSEMENT OF QUALITY OF ANTICOAGULATION WITH VKA IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME Helena Cruz Gomes, Fátima Correia, Luciana Gonçalves, Carla Monteiro, Manuela Carvalho, Beatriz Delgado, Carmo Koch, Graça Oliveira P-0285 ENDOMETRIAL MRNA EXPRESSIONS OF CYTOKINES IN WOMEN WITH IN VITRO FERTILIZATION FAILURE Sadik Sahin, Dilsad Herkiloglu, Enver Ciraci, Sevgin Degirmencioglu, Tayfun Unal, Fikriye Uras, Sermin Tetik P-0361 THE EFFECT OF MYRTUS COMMUNIS EXTRACT ON RENAL INJURY IN RATS WITH BILE DUCT LIGATION Leyla Alev, Burcin Alev-Tuzuner, Sehkar Oktay, Goksel Sener, Aysen Yarat Anticoagulant drugs P-0087 META-ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM Olga Shatalova, Vladislav Gorbatenko, Olga Smuseva, Alexander Maslakov, Andrei Shatalov P-0100 THE TREATMENT OF VENOUS THROMBOEMBOLISM Aliya Toleuova, Dana Tayzhanova, Zhazira Beysenbekova, Zauresh Tauesheva, Zukhra Guseinova, Rakhima Toyynbekova, Olga Visternichan, Ayman Zhusupova, Malina Mandybayeva, Zamira Kenzhetayeva P-0114 APPLICATION OF BASIC AND SPECIAL COAGULATION TESTS FOR MEASURING RIVAROXABAN ACTIVITY Aránzazu García Raso, Rosa Vidal, Aránzazu García Raso, Susana Asenjo, Ana Huertas, Laura Solán, Teresa Arquero, Belén Iñigo, Pilar Llamas P-0372 PRE-EXISTENCE OF PROTHROMBOTIC STATE IN PATIENTS WITH ATRIAL FIBRILLATION DESPITE THERAPY WITH NEW AND TRADITIONAL ANTI-COAGULANT DRUGS Jawed Fareed, Jeff Lifes, Christopher Wanderling, Jordan Liles, Debra Hoppensteadt, Daneyal Syed, Mushabbar Syed M E P-0375 OVINE AND PORCINE HEPARINS EXHIBIT BIOSIMILARITIES IN CONTRAST TO BOVINE COUNTERPARTS Yiming Yao, Olivia Bouchard, Debra Hoppensteadt, Paula Maia, Alice Silva De Castro, Emmanuel Kumar, Nil Guler, Walter Jeske, Daniel Kahn, Jeanine Walenga, Erwin Coyne, Jawed Fareed P-0175 PROTEOLYSIS AND ISOPEPTIDOLYSIS DURING THROMBOLYSIS Sergey Kalabushev, Alexey Kurdyumov, Valentin Manuvera, Nadezhda Antipova, Dmitry Akhaev, Vasiliy Lazarev, Izolda Baskova P-0238 MAJOR BLEEDING COMPLICATIONS DURING CARDIAC ELECTRONIC DEVICE IMPLANTATION IN PATIENTS RECEIVING ANTITHROMBOTIC THERAPY: DO LOCAL TRANEXAMIC ACID HAVE ANY PREVENTIVE ROLE? Osman Beton P-0254 EXPLORING THE SPECIFICITY AND OPTIMAL CONDITIONS FOR EXPRESSING THE MAXIMUM ACTIVITY OF THE NOVEL ANTIPLATELET AGENT VORAPAXAR, IN VITRO Iraklis Moschonas, Styliani Papadaki, Alexandros Tselepis P-0272 IDENTIFICATION OF NEW BIOMARKERS FOR HIGH ON-TREATMENT PLATELET REACTIVITY TO ASPIRIN AND CLOPIDOGREL Maria Tsoumani, Ioannis Ntalas, John Goudevenos, Alexandros Tselepis P-0316 EVALUATION OF RESISTANCE TO STANDARD ANTIPLATELET THERAPY IN PATIENTS UNDERGOING UNSTABLE ANGINA Ludmila Gelis, Alena Miadzvedzeva, Irina Lazarava, Inga Markava, Irina Russkikh, Marina Kaliadka, Tatsiana Rusak, Natallya Shibeka P-0345 EVALUATION OF TIME IN THERAPEUTIC RANGE IN ANTICOAGULATED PATIENTS WITH VENOUS THROMBOEMBOLISM: A SINGLE-CENTER, RETROSPECTIVE, OBSERVATIONAL STUDY Tazi Mezalek Zoubida, Iraqi Fatima-Zohra, Mounfaloti Wafaa, Bourkia Meriem, Ammouri Wafaa, Maamar Mouna, Harmouche Hicham Arterial thrombosis and atherosclerosis P-0091 SERUM URIC ACID AND ALBUMIN LEVELS ARE ASSOCIATED WITH DEEP VENOUS THROMBOSIS Atike Tekeli Kunt, Orhan Findik, Selim Isbir, Seda Gulec Yilmaz, Gokcen Atilboz Alagoz, Emre Murat Altinkilic, Hakan Parlar, Turgay Isbir P-0096 CLINICAL CHARACTERISTICS AND ETIOLOGIES OF ARTERIAL THROMBOSIS: A SERIES OF 45 PATIENTS Thouraya Ben Salem, Molka Togourti, Imed Ben Ghorbel, Monia Khanfir, Mounir Lamloum, Mohamed Habib Houman P-0099 LIPID METABOLISM AND COAGULATION FACTORS IN PATIENTS WITH CORONARY ARTERY DISEASE AFTER STENTING Aliya Toleuova, Zukhra Guseinova, Zhazira Beysenbekova, Zauresh Tauesheva, Rakhima Toyynbekova, Malina Mandybayeva, Olga Visternichan, Ayman Zhusupova, Zhanar Turhanova, Zamira Kenzhetayeva P-0133 RETROSPECTIVE EVALUATION OF PATIENTS WITH ACUTE MESENTERIC ISCHEMIA Süleyman Bademler, Mehmet Ilhan, Ibrahim Fethi Azamat, Abdulmuttalip Baysal, Ali Fuat Kaan Gök, Recep Güloglu, Mehmet Kurtoglu P-0273 ARE AGE AND JAK2V617F MUTATION RELATED TO TROMBOSIS IN CHRONIC MYELOPROLIFERATIVE DISEASES? Pinar Ataca, Erden Atilla, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Hamdi Akan, Onder Arslan, Muhit Ozcan, Meral Beksac, Gunhan Gurman, Osman Ilhan P-0280 SUDDEN ONSET VISION LOSS AS AN INITIAL MANIFESTATION OF ELEVATED SERUM LIPOPROTEIN(A) LEVELS: REPORT OF TWO CASES Huseyin Tokgoz, Umran Caliskan, Mehmet Okka, Hurkan Kerimoglu, Gulfidan Bitirgen Atrial fibrillation P-0041 STUDY OF SAFETY AND EFFECTIVENESS OF DABIGATRAN TO PREVENT THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Juan Jose Cerezo Manchado, Pastora Iniesta, Antonia Melero P-0353 THE PREVENTION OF TROMBOEMBOLIC COMPLICATIONS IN NON-VALVULAR ATRIAL FIBRILLATION G.T. Igimbayeva, Seyed Farzad Jalali, S.A. Salehov, V.Ju. Kolybyuk Coagulation and Tissue factor P-0312 EVALUATION OF PATIENTS WITH HEMOPHILIA; ULUDAG UNIVERSITY EXPERIENCE Hilmi Erdem Gözden, Fahir Özkalemka, Vildan Özkocaman, Tugcan Alp, Zafer Serenli Yeen, Rdvan Ali P-0360 EFFECT OF EXERCISES AND CALORIC RESTRICTION ON SOME BIOCHEMICAL PARAMETERS OF BRAIN TISSUES IN METABOLIC SYNDROME MODEL Nevin Genc-Kahraman, Burcin Alev, Hazal Ipekci, Unsal Veli Ustundag, Tugba Tunali-Akbay, Ebru Emekli-Alturfan, Goksel Sener, Aysen Yarat Coronary, cerebrovascular and peripheral vascular disease P-0053 VERTEBROBASILAR DOLICHOECTASIA AND STROKE RISK FACTORS Birsen Ince, Bengi Gul Alpaslan P-0062 HYPERTRIGLYCERIDEMIA AND ISCHEMIC STROKE Birsen Ince, Zehra Hasiloglu P-0064 ANTIPHOSPHOLIPID ANTIBODIES AND STROKE RECURRENCE IN WOMEN Ayse Deniz Elmali, Birsen Ince P-0076 IS IT TAKAYASU’S ARTERITIS? – EVIDENCE FROM ANGIOGRAPHIC PATTERNS IN SRI LANKA Dewa Pakshage Chula Kanishka Ananda Lal D T L P-0288 SUBOCCLUSIO ARTERIAE SUBCLAVIAE IN A 50-YEAR-OLD WOMEN: CASE REPORT Akif Mlaco, Sanela Vesnic, Demir Bejtovic, Vesna Djurovic-Sarajlic, Abel Baltic P-0326 RISK FACTORS, TREATMENT AND PROGNOSIS OF THROMBOSIS IN CHILDREN, A SINGLE CENTER EXPERIENCE Esra Pekpak, Esra Pekpak, Elif Ince, Talia Ileri, Mehmet Ertem, Hasan Cakmakli, Basak Aksoy, Zumrut Uysal M E P-0349 THE ROLE OF BIOCHEMICAL MARKERS IN ATHEROTHROMBOSIS WITH PLATELET ACTIVATION-RELATED; AN IN VIVO PROSPECTIVE STUDY Sermin Tetik, Tayfun Unal, Koray Ak, Sinan Arsan P-0122 CLINICO-LABORATORY PREDICTORS OF CORONARY RESTENOSIS IN MAN OF KAZAKH NATIONALITY Olga Visternichan, Dana Taizhanova, Elena Zholdybayeva, Pavel Tarlykov P-0158 VENOUS THROMBOSIS IN UNUSUAL SITES: THROMBOPHILIA MARKERS Aya Chakroun Slama, Hela Baccouche, Sonia Mahjoub, Neila Benromdhane P-0161 CEREBRAL AMYLOID ANGIOPATHY AND MRI-VISIBLE PERIVASCULAR SPACES Birsen Ince, Gulcin Benbir Senel P-0271 A COMPARISON OF CILOSTAZOL AND PENTOXIFYLLINE FOR TREATING INTERMITTENT CLAUDICATION.: SYSTEMATIC REVIEW & META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Gehad El Ashal, Ahmed Elgebaly P-0192 ATYPICAL LOCATIONS OF VENOUS THROMBOSIS: A STUDY OF 47 CASES Hamrouni Sarra, Boussetta Najeh, Faida Lajili, Yosra Ben Ariba, Jannet Laabidi, Bassem Louzir, Nadia Ben Abdelhafidh, Salah Othmani P-0347 INTERMITTENT LDL LOWERING THERAPY: RESET THE VASCULAR AGING CLOCK Amina Bico, Azra Kurcehajic, Alden Begic, Mirza Dilic P-0197 THE SPLANCHNIC VENOUS THROMBOSIS: ABOUT 20 CASES Hamrouni Sarra, Najeh Boussetta, Sameh Sayhi, Rim Abid, Jannet Laabidi, Faida Laajili, Bassem Louzir, Nadia Ben Abdelhafidh, Salah Othmani P-0348 WHAT IS DE FACTO SUBCLINICAL ATHEROSCLEROSIS: BIOMARKER, CONDITION OR DISEASE? Azra Kurcehajic, Amina Bico, Alden Begic, Mirza Dilic P-0355 SERUM VITAMIN B12 AND FOLIC ACID LEVELS IN ACUTE CEREBRAL ATHEROTHROMBOTIC INFARCTION Amrane Mounira, Mouhamed Chahine Chekour, Nada Boutrid, Hakim Rahmoun, Boussouf Khaira, Bakhouche Houcher, Ramdane Nasri, Abderrezak Touabti, Moufek Charefeddine Deep vein thrombosis and PE P-0045FORGOTTEN ENEMY. HEMORHEOLOGIC DISTURBANCES CAN LEAD TO THROMBOSIS IN SOME MYELOPROLIFERATIVE NEOPLASMS Eugene Roitman, Irina Kolesnikova, Igor Davydkin, Natalia Kozlova, Eugene Roitman P-0262 ELASTOGRAPHY OF VENOUS THROMBI AT THE ER: IS IT A HELPFUL TOOL? Triantafyllou Evaggelia, Papaevangelou Aggeliki, Pithara Christala, Mihalopoulou Anna P-0074 SYMPTOM OF „IRONED OUT GLUTEAL SULCUS” – A RELIABLE DIFFERENTIAL DIAGNOSTIC “TOOL” FOR THE DIAGNOSIS AND CLINICAL MONITORING OF THE DEEP VENOUS THROMBOSIS (DVT) OF ILIAC VEINS Iovtcho Topalov, Georgi Marinov P-0085 PLATELET VOLUME AS A PROGNOSTIC FACTOR OF PULMONARY THROMBOEMBOLISM Maria Lourdes Posadas-Martinez, Juan Manuel Díaz, Bruno Boietti, Fernán González Bernaldo De Quirós, Veronica Peucheot, Fernando J Vazquez, Liliana Paloma Rojas, Diego Giunta P-0126 THE CORRELATION BETWEEN PLASMA D-DIMER AND PLASMA AND URINE PROTHROMBIN FRAGMENT 1 + 2 IN NON-COMORBID PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS. Fredrik Wexels, Ingebjørg Seljeflot, Are H. Pripp, Ola E. Dahl P-0155 ASSOCIATION OF TISSUE FACTOR PATHWAY INHIBITOR GENE POLYMORPHISMS 399C/T AND 33T/C WITH DEEP VEIN THROMBOSIS Kamal Kishor, Ravi Kumar, Amit Sharma, Hare Ram Pandey, Ravi Ranjan, Pravas Mishra, Renu Saxena P-0198 TOPOGRAPHIC PROFILES OF UNUSUAL LOCATION VENOUS THROMBOSIS DURING VASCULITIS Hamrouni Sarra, Najeh Boussette, Jannet Laabidi, Sameh Sayhi, Nadia Ben Abdelhafidh, Faida Laajili, Salah Othmani P-0206 VENOUS THROMBOEMBOLISM AMONG THE POPULATION OF INTERNAL SECURITY FORCES AGENTS IN TUNISIA Emna Gharbi, Syrine Bellakhal, Maroua Mrouki, Akil Mestiri, Mohamed Hedi Douggui P-0232 INFLUENCE OF DECREASED FIBRINOLYTIC ACTIVITY ON VENOUS THROMBOSIS RISK Biljana Vuckovic, Gorana Mitic, Valentina Djordjevic P-0268 POST-TRAUMATIC PORTAL VEIN THROMBOSIS: A RARE INCIDENT Angeliki Papaevangelou, Evaggelia Triantafyllou, Ekaterini Natsiopoulou, Efstathia Kapnisi, Fotini Statera, Nikolaos Stefanoglou P-0270 VENOUS INJURY: THE ROLE OF MULTI DETECTOR COMPUTED TOMOGRAPHY (MDCT) Angeliki Papaevangelou, Evaggelia Triantafyllou, Ekaterini Natsiopoulou, Panagiota Margari, Maria Vidali, Panagiotis Limiatis, Nikolaos Stefanoglou P-0283 MESENTERIC VENOUS THROMBOSIS IN FUENLABRADA UNIVERSITY HOSPITAL. 28 CASES SERIES ANALYSIS Rafael Cristóbal Bilbao, Barbara Nieto-Sandoval, Cristina Lucía De Ancos-Aracil, Justo Ruíz-Ruíz, Antonio Zapatero-Gaviria P-0287 UNUSUAL LOCALIZATIONS OF DEEP VENOUS THROMBOSIS ABOUT 21 CASES. Emna Gharbi, Syrine Bellakhal, Imen Abdelaali, Taieb Jomni, Mohamed Hedi Douggui M E P-0289 PARKINSON’S DISEASE, HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DANGEROUS COMBINATION Emna Gharbi, Syrine Bellakhal, Zeineb Meddeb, Maroua Mrouki, Istabrak Abdelkafi, Mohamed Hedi Douggui P-0291 MULTIPLE MYELOMA AND THROMBOSIS Elif Umit, Ahmet Muzaffer Demir P-0315 MANAGEMENT OF VENOUS THROMBOEMBOLISM IN CHILDREN IN A SINGLE-PEDIATRIC TERTIARY CARE MEDICAL CENTER. Flor Yus Cebrian, Carmen Coello De Portugal, Nuria Fernandez-Mosteirin, Marcio Andrade, Jose Manuel Calvo Villas P-0185 UPPER LIMBS VENOUS THROMBOSES: A STUDY OF 32 CASES Hana Zoubeidi, Thouraya Ben Salem, Cherifa Abdelkafi, Imed Ben Ghorbel, Monia Khanfir, Mounir Lamloum, Mohamed Habib Houman P-0322 PARTICULARITIES OF PULMONARY EMBOLISM: AN INTERNAL MEDICINE DEPARTMENT EXPERIENCE Emna Gharbi, Syrine Bellakhal, Badreddine Ben Kaab, Akil Mestiri, Mohamed Hedi Douggui P-0191 VENA CAVA THROMBOSES: A STUDY OF CLINICAL AND ETIOLOGICAL FEATURES OF 42 CASES Ines Naceur, Thouraya Ben Salem, Molka Togourti, Imed Ben Ghorbel, Monia Khanfir, Mounir Lamloum, Mohamed Habib Houman P-0354 PLASMA TOTAL HOMOCYSTEINE LEVELS AND OTHER BIOCHEMICAL PARAMETERS IN ALGERIAN PATIENTS WITH DEEP VEIN THROMBOSIS Amrane Mounira, Kheira Boussouf, Zahira Houcher, Samia Begag, Bakhouche Houcher, Abderrezak Touabti P-0366 SELECTION OF BIOLOGICAL MARKERS OF HYPERCOAGULABILITY FOR THE IDENTIFICATION OF HIGH VTE RISK PATIENTS WITH LUNG ADENOCARCINOMA. THE ROADMAP STUDY I. Evmorfiadis, P. Boura, A. Rousseau, A. Charpidou, G. Giozos, P. Van Dreden, K. Syrigos, A. Larsen, Ismail Elalamy, G. T. Gerotziafas P-0367 A NEW RISK ASSESSMENT MODEL FOR VTE IN AMBULATORY PATIENTS WITH LUNG ADENOCARCINOMA ON CHEMOTHERAPY. THE ROADMAP STUDY Gerotziafas G, Evmorfiadis I, Boura P, Giozos G, Charpidou A, Rousseau A, Van Dreden P, Grusse M, Annette Larsen, Syrigos K, Ismail Elalamy Diagnostic and laboratory methods P-0070 DISTRIBUTION OF PLATELET AND PLATELET INDICES DUE TO AGE Yasemin Ardicoglu Akisin, Mehmet Nejat Akar P-0089 EVALUATION OF VITAMIN K ANTAGONISTS ANTICOAGULATION EFFECT Tatjana Makarovska-Bojadzieva, Velkova Emilija, Milenka Blagoevska, Julija Samonikov Tosevska, Violeta Dejanova Ilijevska, Jasminka Nikolova Diagnostic and laboratory methods P-0093 THE ROLE OF PLATELET-TO-LYMPHOCYTE RATIO IN THE DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS Zeynep Nur Karagoz, Yasemin Ardicoglu Akisin, Mustafa Turan, Mehmet Nejat Akar P-0154 ANTIBODIES TO FACTOR XII DIAGNOSED AT THE TIME OF LABOR FOLLOWING VARICELLA INFECTION DURING PREGNANCY: A CASE REPORT Sassi Mouna, Abderrazak Fatma, Baccouche Héla, Zrelli Amira, Chatti Najla, Hassine Mohsen, Babba Hamouda P-0157 THROMBOPHILIA ASSESSMENT IN PATENTS WITH VENOUS THROMBOEMBOLISM Tatjana Makarovska-Bojadzieva, Emilija Velkova, Milenka Blagoevska, Julija Samonikov Tosevska, Anita Hristova Dimceva P-0207 REVIEW OF D-DIMER PROFICIENCY TESTING DATA WITH RESPECT TO DIFFERENT CONTROL SAMPLE TYPE Jasna Lenicek Krleza, Ana Bronic Disseminated Intravascular coagulation P-0227 GASTRIC DENOCARCINOMA WITH BONE MARROW CARCINOMATOSIS COMPLICATED WITH CANCER RELATED THROMBOTIC MICROANGHIOPATHY Semih Gulle P-0311 THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY Erden Atilla, Pinar Ataca, Ugur Sahin, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Taner Demirer, Muhit Ozcan, Hamdi Akan, Meral Beksac, Gunhan Gurman, Osman Ilhan P-0369 COMPARISON OF THE COAGULATION ABNORMALITIES IN PATIENTS WITH DIC COMPARED TO WARFARINIZED PATIENTS Jawed Fareed, Amanda Walborn Daniel Kahn, Mark Williams, Debra Hoppensteadt Fibrinogen and other coagulation factors P-0131 A HEMOPHILIA CASE WHO ‘S DIAGNOSED LYMPHOMA AND TREATED WITH CHEMOTHERAPY Handan Sahin, Vahap Okan Okan, Mehmet Yilmaz, Mustafa Pehlivan, Ibrahim Sari, Ali Caner Ozdover P-0179AN ACQUIRED FVII DEFICIENCY AND HYPOFIBRINOGENAEMIA FOLLOWING AN HEMATOPOIETIC STEM CELL TRANSPLANTATION Hela Baccouche, Amel Lakhal, Sonia Mahjoub, Aya Chakroun, Tarek Ben Othman, Neila Ben Romdhane P-0313 ACQUIRED DEFICIENCY OF VITAMIN K-DEPENDANT CLOTTING FACTORS, DESCRIPTIVE REPORT OF 3 CASES, SINGLE CENTRE EXPERIENCE Isil Erdogan Ozunal, Ayse Salihoglu, Nurgul Ozgur Yurttas, Dilek Keskin, Sevil Sadri, Selin Berk, Fevzi Firat Yalniz, Ahmet Emre Eskazan, Seniz Ongoren, Teoman Soysal, Yildiz Aydin, Zafer Baslar, Muhlis Cem Ar P-0314 HYPOFIBRINOGENEMIA; DESCRIPTIVE REPORT OF 5 CASES, SINGLE CENTRE EXPERIENCE Ece Vural, Isil Erdogan Ozunal, Ayse Salihoglu, Nurgul Ozgur Yurttas, Dilek Keskin, Sevil Sadri, Selin Berk, Fevzi Firat Yalniz, Tugrul Elverdi, Ahmet Emre Eskazan, Muhlis Cem Ar, Seniz Ongoren, Teoman Soysal, Yildiz Aydin, Zafer Baslar D T L P-0221 SHORT EVALUATION OF FIBRINOGEN DETERMINATION BY DADE THROMBIN REAGENT ON SYSMEX CA 1500 ANALYSER Ana Bronic, Marina Pavic P-0222 COAGULATION LABORATORY NETWORK IN REPUBLIC OF CROATIA Ana Bronic, Desiree Coen Herak, Sandra Margetic, Marija Milic M E P-0260 RETROSPECTIVE EVALUATION OF PATIENTS WITH FACTOR XI DEFICIENCY: RESULTS FROM A SINGLE CENTRE Sevil Sadri, Isil Erdogan Ozunal, Selin Berk, Dilek Keskin, Nurgul Ozgur Yurttas, Ayse Salihoglu, Ahmet Emre Eskazan, Seniz Ongoren, Muhlis Cem Ar, Teoman Soysal, Zafer Baslar P-0274 ASSOCIATIONS BETWEEN COMPLETE BLOOD COUNT RESULTS AND D- DIMER LEVEL IN PATIENTS WITH ARTERIAL OR VENOUS THROMBOSIS Zuhre Kaya P-0320 HEMOPHILIA: A SINGLE-CENTRE EXPERIENCE OF 12 YEARS Hande Kizilocak, Gül Nihal Ozdemir, Gürcan Dikme, Begüm Koc, Tiraje Celkan Fibrinolysis and thrombolysis P-0051 EFFECT OF ANTIHYPERTENSIVE DRUGS ON THE ACTIVITY OF PROTEASES OF THE FIBRINOLYTIC SYSTEM IN VITRO Roza Aisina, Lilia Mukhametova, Karina Gershkovich, Sergei Varfolomeyev Genetics and genomics in thrombosis and Hemostasis P-0102 SCREENING OF EPCR VARIANTS AND THEIR CORRELATION WITH FACTOR V LEIDEN AND PROTHROMBIN 20210A MUTATIONS IN TURKISH PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA Dilara Fatma Akin, Deniz Aslar Oner, Kadir Sipahi, Mine Mumcuoglu, Emin Kurekci, Ustun Ezer, Nejat Akar P-0106 THE ASSOCIATION OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/5G POLYMORPHISM AND FACTOR V LEIDEN (FVL) MUTATION IN PEDIATRIC ACUTE LEUKEMIA PATIENTS Dilara Fatma Akin, Deniz Aslar Oner, Mine Mumcuoglu, Emin Kurekci, Ustun Ezer, Nejat Akar P-0169 ASSOCIATION OF MDR1 C3435T AND G2677T/A POLYMORPHISMS WITH PLASMA PLATELET ACTIVATING FACTOR LEVELS AND ADP-INDUCED PLATELET FUNCTIONS IN CORONARY ARTERY DISEASE PATIENTS Turgut Ulutin, Gulsel Ersoy Ayaz, Bahadir Batar, Gonul Kanigur, Mehmet Guven, Ilhan Onaran, Bilgehan Karadag, Baris Ilerigelen, Ahmet Dirican P-0182 FIRST OBSERVATION OF TUBB1 GENE MUTATIONS IN TURKISH PATIENTS WITH MACROTHROMBOCYTOPENIA Didem Torun Ozkan, Abdullah Abdul Waheed, Ayten Kandilci, Nejat Akar P-0194 ASSOCIATION OF CANDIDATE GENES POLYMORPHISM WITH PLATELET FUNCTION AND CARDIOVASCULAR EVENTS ZAPROVALNA O. SI “L.T.MALAYA THERAPY INSTITUTE NAMSU”, KHARKIV, UKRAINE Olga Zaprovalna P-0205 RELATIONSHIP BETWEEN ACROMEGALY AND GROWTH ARREST-SPECIFIC GENE 6 Fikriye Uras, Nihan Verimli, Ozlem Bingol Ozakpinar, Dilek Yavuz Gogas P-0265 MTHFR C677T POLYMORPHISM AND THROMBOTIC COMPLICATIONS IN SICKLE CELL DISEASE PATIENTS Iakovos Armenis, Vasiliki Kalotychou, Zoe Kontogeorgiou, Reveka Tzanetea, Konstantinos Pantos, Konstantinos Konstantopoulos, Ioannis Rombos P-0351 CUTANEOUS NECROSIS REVEALING PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA. A NEW CASE Tazi Mezalek Zoubida, Bouigua Nisrine, Harmouche Hicham, Bourkia Meriem, Mounfaloti Wafaa, Ammouri Wafaa, Maamar Mouna, Adnaoui Mohamed P-0357 THE EFFECT OF TMRPSS6 (RS2235324, RS855791, RS2111833) POLYMORPHISMS ON RED BLOOD CELL LEVELS IN IRON DEFICIENCY ANAEMIA Tuba Mutlu, Serap Yavuzer, Isil Bavunoglu, Mahir Cengiz, Hakan Yavuzer, Yusuf Ziya Erzin, Aydin Tunckale, Meltem Mete, Mehmet Guven Hemostasis and inflammation P-0292 SUPERFICIAL VENOUS THROMBOSIS: A SERIOUS CONDITION Emna Gharbi, Syrine Bellakhal, Badreddine Ben Kaab, Akil Mestiri, Mohamed Hedi Douggui P-0334 PROMPT DIAGNOSE AND TREATMENT OF ACQUIRED HEMOPHILIA A: A CASE REPORT Filipe Vasconcelos, Manuela Carvalho, Luciana Goncalves Ricca, David Aranda, Carmo Koch P-0344 THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA PATIENTS: SINGLE CENTER EXPERIENCE Mustafa Merter, Ugur Sahin, Mehmet Gunduz, Zehra Narli Ozdemir, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topcuoglu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac, Hamdi Akan, Gunhan Gurman, Meltem Kurt Yuksel Hemostasis, Thrombosis and malignancy P-0376 INFLAMMATION AND HEMOSTATIC ACTIVATION MAY CONTRIBUTE TO POSTSURGICAL THROMBOSIS IN PATIENTS WITH BLADDER CANCER Schuharazad Abro, Melanie Clark, Guliz Barkan, Debra Hoppensteadt, Jawed Fareed, Eva Wojick, Marcus Quek Heparins and heparin induced thrombocytopenia P-0319 DABIGATRAN USE FOR MANAGEMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH CANCER-RELATED THROMBOSIS Luciana Goncalves Ricca, Manuela Carvalho, Ana Leite, Gabriela Fernandes, Filipe Vasconcelos, Carmo Koch M E Lupus anticoagulant/ Phospholipid dependent antibodies P-0150 THROMBOSES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME Thouraya Ben Salem, Ines Naceur, Cherifa Abdelkafi, Imed Ben Ghorbel, Mounir Lamloum, Mohamed Habib Houman P-0178 ANTIPHOSPHOLIPID ANTIBODIES IN MYELOPROLIFERATIVE DISEASE: RELATIONSHIP WITH JAK2 V617F STATUS AND THROMBOTIC PROFILE Hela Baccouche, Montaha Ben Jemaa, Aya Chakroun, Sonia Mahjoub, Houria Lahmar, Lilia Laadhar, Mariam Sallami, Neila Ben Romdhane P-0251 ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA Sahika Sahinkaya, Huseyin Tokgoz, Umran Caliskan P-0256 MPL W515 K MUTATION IN A PEDIATRIC CASE OF ESSENTIAL THROMBOCYTHEMIA PRESENTING WITH BUDD-CHIARI SYNDROME Huseyin Tokgoz, Umran Caliskan, Reyhan Kucukkaya, Veysel Sabri Hancer P-0264 BONE MARROW NECROSIS AND PULMONARY THROMBOSIS ASSOCIATED WITH ANTIPHOSPHOLIPID SYNDROME Huseyin Tokgoz, Umran Caliskan P-0296 A CASE OF AN ANTITHROMBIN DEFICIENCY WITH MESENTERIC THROMBOSES AND CEREBRAL INFARCT Tugcan Alp, Vldan Ozkocaman, Fahr Ozkalemkas, Cemle Sanl, Hlm Erdem Gozden, Zafer Serenl Yegen, Rdvan Al P-0298 MULTIPLE TROMBOSES, HEMOLYTIC ANEMIA; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME, A CASE REPORT Tugcan Alp, Srn Zelal Trnova, Hlm Erdem Gozden, Tuba Ersal, Fahr Ozkalemkas, Vldan Ozkocaman, Rdvan Al Microparticles P-0195 DR. TUBA HILKAY KARAPINAR Burcak Tatli Gunes, Meral Turker, Salih Gozmen, Yilmaz Ay, Berna Atabay, Yesim Oymak, Dilek Ince, Tuba Hilkay Karapinar, Gulcihan Ozek, Canan Vergin P-0210 PHOSPHOLIPID DEPENDENT PROCOAGULANT ACTIVITY EXPRESSED BY CIRCULATING MICROPARTICULES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS Hela Baccouche, Montaha Ben Jemaa, Sonia Mahjoub, Aya Chakroun, Zeineb Manai, Neila Ben Romdhane Perinatal and pediatric hemostasis P-0119 THE ASSESSMENT OF PROTHROMBOTIC POTENTIAL USING THROMBIN GENERATION ASSAY IN PATIENTS WITH NEPHROTIC SYNDROME IN CHILDHOOD Eren Soyaltin, Yilmaz Ay, Yilmaz Ay, Erkin Serdaroglu, Yesim Oymak, Tuba Hilkay Karapinar, Canan Vergin P-0247 INHERITED PROTHROMBOTIC RISK FACTORS IN MOTHER-CHILD PAIRS AND PERINATAL STROKE Jasna Lenicek Krleza, Ana Grzunov, Desiree Coen Herak, Vlasta Duranovic, Renata Zadro P-0249 IMPACT OF AGE ON GENERAL FEATURES OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN TRAKYA REGION, TURKEY Elif Umit, Ahmet Muzaffer Demir P-0282 THE IMPORTANCE OF OXIDATIVE STRESS IN ABNORMALITIES OF PLATELET FUNCTION. THE RETROSPECTIVE STUDY IN CHRONIC MYELOID LEUKEMIA AND MYELODISPLASTIC SYNDROME PATIENTS Viola Maria Popov, Maria Minodora Iordache, Eugenia Kovacs, Mihaela Georgeta Moisescu, Mihaela Tevet, Ana Maria Vladareanu, Horia Bumbea, Meilin Murat, Tudor Savopol P-0307 IBRUTINIB AND AGGREGATION Juraj Sokol, Juraj Chudej, Ingrid Skornova, Lukas Duraj, Matej Hrncar, Andrej Rosik, Peter Kubisz, Jan Stasko P-0323 THERAPEUTIC THROMBOCYTAPHERESIS: HIGHER PLATELET COUNTS SHOULD MATTER Zehra Narli, Ugur Sahin, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Selami Kocak Toprak, Pervin Topcuoglu, Muhit Ozcan, Onder Arslan, Taner Demirer, Meral Beksac, Gunhan Gurman, Osman Ilhan Pregnancy and thrombosis P-0297 THE ROLE OF T CELLS AND SOME CYTOKINS IN ENDOMETRIAL TISSUE IN UNEXPLAINED INFERTILITY Enver Ciraci, Sadik Sahin, Sevgin Degirmencioglu, Dilsad Herkiloglu, Bulent Tekin, Tayfun Unal, Sermin Tetik P-0341 A CASE OF OBSTRETRIC CEREBRAL VENOUS SINUS THROMBOSIS: CT AND MRI FINDINGS Triantafyllou Evaggelia, Papaevangelou Angeliki, Pithara Christala, Mihalopoulou Anna, Papaioannou Dimitrios, Stefanoglou Nikolaos Regenerative medicine and tissue engineering P-0202 GROWTH ARREST-SPECIFIC 6 PROTEIN AFFECTS DIFFERENTIATION OF MESENCHYMAL STEM CELLS INTO OSTEOGENIC, CHONDROGENIC AND ADIPOGENIC CELLS Fikriye Uras, Nese Eriz, Ozlem Bingol Ozakpinar, Naziye Ozkan D T L P-0276 LONG-TERM FOLLOW-UP OF TWO CHILDREN WITH RECURRENT IMMUNE THROMBOCYTOPENIC PURPURA Zuhre Kaya M E Platelets and Megakaryocytes P-0215 INVESTIGATION OF CLINICAL SIGNIFICANCE OF PLATELET DYSFUNCTION IN PATIENTS WITH THROMBOCYTOPENIA Mehmet Can Ugur, Fatma Demet Ince, Cengiz Ceylan, Harun Akar, Kaan Kavakli Surgery: Hemostasis and Thrombosis P-0044 NEW HAEMOSTATIC DRUG BASED ON A SYNTHETIC TRIPEPTIDE INHIBITOR OF PLASMIN Lilia Mukhametova, Roza Aisina, Tatiana Voyushina, Sergei Varfolomeyev, Sergei Yarotsky EXHIBITOR FLOOR PLAN FENER AUDITORIUM TOPHANE AUDITORIUM 17 15 16 EYUP AUDITORIUM 20 21 22 23 24 10 12 9 14 EXHIBITION AREA REGISTRATION DESK POSTERS AREA stand nº 9-10 stand nº 12 stand nº 14 stand nº 20 stand nº 21 stand nº 22 M E stand nº 15-16 stand nº 17 stand nº 23 stand nº 24 Special prepublication offer: CHF 75.00 / EUR 70.00 / USD 88.00 SickKids Handbook of Pediatric Thrombosis and Hemostasis Coming soon! 2nd, revised edition Editors Victor S. Blanchette Leonardo R. Brandão Vicky R. Breakey Shoshana Revel-Vilk This updated edition of the SickKids Handbook takes the reader through the entire field of pediatric thrombosis and hemostasis. An introductory section concisely explains the complex pathophysiology of hemostasis and thrombosis. The chapters that follow include practical, evidence-based information on the diagnosis and management of inherited and acquired bleeding disorders and thrombotic events of the venous, arterial, cardiac and central nervous systems that affect children. Special features include practical clinical algorithms and appendices that cite normal laboratory reference ranges, as well as recommended dosages of blood products and major hemostatic agents. A stand-alone chapter is dedicated to developmental hemostasis and bleeding in the neonate. A chapter on antithrombotic therapy in children gives succinct information on the old and new anticoagulants, antiplatelet drugs and thrombolytic agents. Written and reviewed by international experts in the field, this handbook is intended for health care professionals involved in the assessment and care of children with inherited and acquired bleeding and clotting disorders, including general and specialist pediatricians (in particular intensivists, neonatologists, cardiologists/cardiac surgeons, rheumatologists and nephrologists), hematologists/oncologists (pediatric and adult), as well as medical trainees, nurses, nurse practitioners and pharmacists. Review from the first edition: I recommend the handbook to all paediatricians treating children with bleeding and thromboembolic disorders. This is a book we have been waiting for. At our ward, we found the recommendations we needed to work out femoral artery thrombosis, anticoagulation in cardiomyopathy and investigation of bleeding disorders by reading this handbook. Ellen Ruud, Acta Paediatrica, Vol. 103, No. 1, 2014 Fields of Interest; Hematology, Cardiology, Intensive Care, Neonatology, Neurology, Nursing, Oncology, Pediatrics, Pharmacology Order Form SickKids Handbook of Pediatric Thrombosis and Hemostasis 2nd, revised edition Editors: V.S. Blanchette; L.R. Brandão (Toronto, Ont.); V.R. Breakey (Hamilton, Ont.); S. Revel-Vilk (Jerusalem) approx. XV + 279 p., 23 fig., 59 tab., soft cover, 2016 Special prepublication price: CHF 75.00 / EUR 70.00 / USD 88.00 Prices subject to change, VAT not included EUR price for eurozone countries, USD price for USA and Latin America only ISBN 978–3–318–03026–6 (soft cover) e-ISBN 978–3–318–03027–3 w w w.karger.com/sick k ids Please send: Name/Address: Postage and handling free with prepayment Payment: Please charge to my credit card American Express Diners MasterCard Visa M E Card No.: Exp. date: CVV/CVC (3 digits in the signature field on the back of Visa and MasterCard) Check enclosed Please bill me Karger – Medical and Scientific Publishers CH–4009 Basel, Switzerland orders@karger.com, f: +41 61 306 12 34 www.karger.com 24KI16309p D T L copy/ies Date: Signature: Volumes 115 and 116 in 2016 6 issues per volume | ISSN 0340-6245 Today’s Science for Tomorrow’s Results Thrombosis and Haemostasis is the official Organ of the Working Groups "Thrombosis" and "Atherosclerosis and Vascular Biology" of the European Society of Cardiology (ESC), the Sociedad Española de Trombosis y Hemostasia (SETH), the Australian Vascular Biology Society (AVBS) and the Gesellschaft für Thrombose- und Hämostaseforschung (GTH). Impact Factor 2014: 4.984! Thrombosis and Haemostasis publishes original contributions of basic and original research and clinical studies in vascular biology and medicine, serving as an international platform for the dissemination and debate of scientific information. The Journal appears monthly in both print and online. Visit our homepage and register for eTOC today at: www.thrombosis-online.com ORDER NOW: FAX ORDER: +49 711 22987-85 E-MAIL: claudia.boehm@schattauer.de Street / P.O. Box City / state / ZIP code Country Phone / fax / e-mail Date / signature All prices are subject to change without notice T L M E Subscription Rates – Print and Online: Thrombosis and Haemostasis 2016. Volume 115 and 116 (6 issues per volume) Institutes First name / last name Subscribers to and readers of Thrombosis and Haemostasis enjoy • A reliable publication platform in vascular biology and medicine • Renowned authors – leaders in their field of research • Electronic Table of Contents – register online today! • Online submission and TH First: epub ahead of print • A broad scope covering expanded areas of interest including: - Coagulation and Fibrinolysis - Cellular Haemostasis and Platelets - Blood Cells, Inflammation and Infection - Endothelium and Angiogenesis - Cellular Signalling and Proteolysis - New Technologies, Diagnostic Tools and Drugs - Stroke, Systemic or Venous Thromboembolism - Atherosclerosis and Ischaemic Disease € 1132.001 Individuals € 456.001 Members ESC, ISTH, AVBS € 228.001 1 EU: Mailing costs included. Our subscriptions are Media-Subscriptions (print + online), for which the subscription price is divided into 90 % representing the print content and 10 % representing the online content. For orders delivered within the European Union, 7 % VAT for the print content and the applicable VAT rate depending on country of destination for the online content will be added to the subscription price. Overseas: As above plus mailing costs € 48.00 Payment: Please bill me Please charge my credit card Visa MasterCard Card number Expiration date Card authorisation number I hereby authorise you to invoice me as above. Please enter my subscription starting with month: _____ Cancellation Policy: The Journal and the invoice will be sent directly by the Publisher Schattauer GmbH, Hoelderlinstrasse 3, 70174 Stuttgart, Germany, CEO Dieter Bergemann, Dipl.-Psych. Dr. med. Wulf Bertram, Jan Haaf, Court of Registration Stuttgart HRB 3357. Orders can be cancelled within 14 days. Cancellations are accepted from date of postage. Any cancellation must, however, be made in writing by post, email or fax. The subscription will be automatically renewed, unless cancellation notice is received by September 30th. Date / 2nd signature I agree to receiving info material and newsletters by mail or e-mail from Schattauer Publishers. I can cancel this at any time by sending an e-mail to info@schattauer.de. My data are collected in accordance with current German data privacy protection laws. 25 Biennial international Congress on thromBosis 23-26 May, 2018 Palazzo del Cinema - Venice Convention Center Venice, Italy 26 D T L M E www.thrombosis2018.org SPONSORS OFFICIAL JOURNAL T L M E MEDIA PARTNERS 27 www.thrombosis2016.org European and Mediterranean League against Thrombotic Diseases EMLTD M E D T L Technical Secretariat GESTIÓN DE CONGRESOS Y SOCIEDADES www.geyseco.es Phone (+34) 963511632 Fax (+34) 963942558 secretariat_emltd@geyseco.es T L